Complement your
therapy with personalized
microbiome solutions.
Our advanced, clinical-grade microbiome sequencing, intelligence, and profiling technology is dedicated to decoding and modulating the microbiome to optimize immune function—specifically enhancing therapeutic strategies for Inflammatory Bowel Disease (IBD), oncology and oral health.
10 years
Cumulated research and studies embedded in our technology.
90%
of IBD patients get into full
sustained remission.
94%
of pediatric patients respond
in less than a month
26%
increase in oncological
therapy response.
Our Solutions
for You
Our focus is on Intestinal Bowel Disease (IBD), oncology and oral health.
​To better understand your microbiome and its inflammatory signature in relation to your health concerns, you will begin with one of our microbiome intelligence panels. Using millions of data points, a comprehensive profile of your condition, and insights from your medical history, our technology will pinpoint the unique inflammatory markers in your microbiome. Based on this analysis, we will develop a tailored action plan to regulate inflammation and restore balance.
Microbiome Intelligence Panels for
.jpg)
Beyond today's standard of personalization
Before your recommendation is generated our technology considers:
We detect the hidden
chemical causes of your disease
Your microbiome is the largest producer of chemical metabolites that interact with your immune and metabolic health.
We detect each patient's dynamic inflammatory microbiome signatures connected with their medical condition. We predict the impact load of the microbiome on the immune system and enhance the effectiveness of existing therapies
Who we are
We are a health and technology company uniting scientific advancements, artificial intelligence, biology, genetics, and medicine.
Our mission is to harness microbiome insights as a key factor in enhancing therapies for inflammatory bowel disease, cancer, and oral health, significantly improving the efficacy of existing treatments and bringing hope to millions.
Endorsed by industry leaders
We believe advanced personalization and microbiome modulation will lead to a revolution in immunotherapy
We leverage AI, DNA testing, advanced data profiling, and applied science to accelerate the ability of patients worldwide to complement their therapies.
By doing so, we significantly enhance the likelihood of success for conditions where standard treatments have traditionally offered limited effectiveness, such as IBD, cancer, and autoimmune diseases.